Michelle Gallaher is an award-winning health technology entrepreneur with a particular interest in artificial intelligence, clinical trials and ethics. Recently commencing as the inaugural CEO of Cerulea Clinical Trials, Michelle’s current focus is on building a world-leading ophthalmic clinical trials site specialising in gene therapy trials, medical devices, and applying emerging efficiency technology solutions. 

This episode was recorded on 24 September 2024 

--- 

Connect with us on Twitter at @MDHSdiversity or by email at [email protected] 

The views, thoughts, and opinions expressed are the speaker’s own and do not represent the views, thoughts, and opinions of the University of Melbourne. The material and information presented here is for general information purposes only. Find out more about our Inspiring Webinar series: https://go.unimelb.edu.au/ik7i 

See omnystudio.com/listener for privacy information.